✦ LIBER ✦

A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor

✍ Scribed by Mickaël Montembault; Giang Vo-Thanh; Abdallah Deyine; Valérie Fargeas; Monique Villiéras; Ané Adjou; Didier Dubreuil; Didier Esquieu; Catherine Grégoire; Sandrine Opi; Jean-Marie Péloponèse; Grant Campbell; Jennifer Watkins; Jean de Mareuil; Anne-Marie Aubertin; Christian Bailly; Erwann Loret; Jacques Lebreton

Book ID: 108073209
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 194 KB
Volume: 14
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2003.12.095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Possible Improvement for Structure-Bas

A Possible Improvement for Structure-Based Drug Design Illustrated by the Discovery of a Tat HIV-1 Inhibitor.

✍ Jacques Lebreton; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 165 KB 👁 2 views

Structure-based drug design of nonpeptid

Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitors

✍ Vincent J. Kalish; John H. Tatlock; Jay F. Davies II; Stephen W. Kaldor; Bruce A 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

The cocrystal structures of LY289612 and LY297135 were used as a starting point in the design of nonpeptidic HIV-1 protease inhibitors. This report details the discovery of a series of novel aromatic P2 replacement groups. The 3-hydroxy-2-methyl benzoic acid group, discovered in AG1254, was incorpor

Computer modeling of promising inhibitor

Computer modeling of promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-AIDS drug design

✍ A. M. Andrianov; I. V. Anishchenko 📂 Article 📅 2010 🏛 Pleiades Publishing 🌐 English ⚖ 852 KB

Increased drug reactions in HIV-1-positi

Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease

✍ K.J. SMITH; H.G. SKELTON; J. YEAGER; R. LEDSKY; T.-H. NG; K.F. WAGNER; THE MILIT 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Structure-based design of achiral, nonpe

Structure-based design of achiral, nonpeptidic hydroxybenzamide as a novel P2/P2′ replacement for the symmetry-based HIV protease inhibitors

✍ Ramnarayan S. Randad; Lucyna Lubkowska; Abelardo M. Silva; Diego M.A. Guerin; Se 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 737 KB

A combination of structure-activity studies, kinetic analysis, X-ray crystallographic analysis, and modeling were employed in the design of a novel series of HIV-1 protease (HIV PR) inhibitors. The crystal structure of a complex of HIV PR with SRSS-2,5-bis[N-(tert-butyloxycarbonyl)amino]-3,4-dihydro

PRO_SELECT: Combining Structure-Based Dr

PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors

✍ Liebeschuetz, John W.; Jones, Stuart D.; Morgan, Phillip J.; Murray, Chris W.; R 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 318 KB